COMMUNIQUÉS West-GlobeNewswire

Autolus Therapeutics to Host R&D Day on March 26, 2019
07/03/2019
Company to highlight next-generation, novel programmed T cell therapies in development for hematological and solid tumor indications Program and webcast to begin at 8:00 am ET LONDON, March 07, 2019 (GLOBE NEWSWIRE) -- [...]
HTG Molecular Diagnostics Reports Full Year 2018 Results
07/03/2019
Revenue increased 46% in 2018 compared to the prior year reflecting continued success growing the company’s profiling business with Pharma company customers TUCSON, Ariz., March 07, 2019 (GLOBE NEWSWIRE) -- HTG [...]
Integra LifeSciences to participate in Healthcare Conference in March 2019
07/03/2019
PLAINSBORO, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in March: [...]
Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, [...]
Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events
07/03/2019
Conference Call Scheduled for 4:30 p.m. ET today MENLO PARK, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and full year ended [...]
RTI Surgical® Shareholders Approve Paradigm Spine Acquisition
07/03/2019
ALACHUA, Fla., March 07, 2019 (GLOBE NEWSWIRE) -- RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced its shareholders have voted to approve completion of the company’s previously [...]
The Joint Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
- Increases Annual System-Wide Gross Sales 30%, Compared to 2017 - - Achieves Positive Annual Net Income for the First Time of $253,000 - - Sells 99 Franchise Licenses in 2018, Up from 37 in 2017 - SCOTTSDALE, Ariz., [...]
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Provides Full Year 2019 Financial Outlook SANTA CLARA, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the [...]
MRI Interventions Announces Agreement with Siemens Healthineers For Interfacing with the Portfolio of Magnetom MRI Scanners
07/03/2019
Agreement Enables the Development of More Efficient Clinical Workflows, Advanced Functionality and Shorter Surgical Procedure Times In the MRI Suite IRVINE, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, [...]
Alphatec Spine Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Secures Additional $30M Financing Commitment from Squadron Capital CARLSBAD, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced financial results [...]
Harpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Webcast and Conference Call to be Held at 4:30 p.m. ET on March 14, 2019 SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company [...]
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
07/03/2019
On Track to Dose First Patient in Pivotal Phase 3 Trial of Pegzilarginase for ARG1-D in Q2 of 2019 Initiated IND-Enabling Studies for New Pipeline Programs Progress with Pegzilarginase Cancer Indication-Phase 2 [...]
Aravive Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Corporate Updates
07/03/2019
HOUSTON, March 07, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company focused on developing innovative therapies that target important survival pathways for cancer, [...]
Profound Medical Announces Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
TORONTO, March 07, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care Zika/Chikungunya/Dengue Tests and Micro Readers
07/03/2019
MEDFORD, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that it will be awarded a conditional Long [...]
La Jolla Pharmaceutical Company to Present at the 39th Annual Cowen Healthcare Conference
07/03/2019
SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
ChromaDex Corporation Reports 2018 Financial Results
07/03/2019
- Full Year 2018 Net Revenues Increased by 49% to $31.6 Million and Fourth Quarter 2018 Net Revenues Increased by 20% to $9.1 Million - Fourth Quarter 2018 Highlights vs. Fourth Quarter 2017 Entered into a global [...]
T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
07/03/2019
Secured 14 New Instrument Contracts in the Fourth Quarter and 39 total New Instrument Contracts in 2018 that are expected to drive growth in Recurring Test Revenue Confirms Guidance of a Doubling of Revenue in 2019; [...]
Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
07/03/2019
- Clinical trial results expected for AB-506, a potent capsid inhibitor, and AB-729, a subcutaneously administered RNAi agent targeting HBsAg - Ongoing analyses of AB-452, a novel orally-available RNA destabilizer, with [...]

Pages